Testing Cabozantinib in Patients With Advanced Pancreatic Neuroendocrine and Carcinoid Tumors
Summary
The lay summary the sponsor registered on ClinicalTrials.gov.
Investigators
The overall officials registered on this study. Names that resolve to a FindMyKOL profile link to it; the rest are shown as registered.
- Jennifer A Chan
Alliance for Clinical Trials in Oncology
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
432 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Katmai Oncology Group
Anchorage, Alaska, United States
- Kingman Regional Medical Center
Kingman, Arizona, United States
- Mayo Clinic Hospital in Arizona
Phoenix, Arizona, United States
- Banner University Medical Center - Tucson
Tucson, Arizona, United States
- University of Arizona Cancer Center-North Campus
Tucson, Arizona, United States
- University of Arkansas for Medical Sciences
Little Rock, Arkansas, United States
- Kaiser Permanente-Deer Valley Medical Center
Antioch, California, United States
- Pcr Oncology
Arroyo Grande, California, United States
- Sutter Auburn Faith Hospital
Auburn, California, United States
- Alta Bates Summit Medical Center-Herrick Campus
Berkeley, California, United States
- Mills-Peninsula Medical Center
Burlingame, California, United States
- City of Hope Comprehensive Cancer Center
Duarte, California, United States
- Epic Care-Dublin
Dublin, California, United States
- Epic Care Partners in Cancer Care
Emeryville, California, United States
- Kaiser Permanente-Fremont
Fremont, California, United States
- Palo Alto Medical Foundation-Fremont
Fremont, California, United States
- Kaiser Permanente-Fresno
Fresno, California, United States
- Contra Costa Regional Medical Center
Martinez, California, United States
- Fremont - Rideout Cancer Center
Marysville, California, United States
- Kaiser Permanente-Modesto
Modesto, California, United States
- Memorial Medical Center
Modesto, California, United States
- Palo Alto Medical Foundation-Camino Division
Mountain View, California, United States
- Alta Bates Summit Medical Center - Summit Campus
Oakland, California, United States
- Kaiser Permanente-Oakland
Oakland, California, United States
- Palo Alto Medical Foundation Health Care
Palo Alto, California, United States
- Stanford Cancer Institute Palo Alto
Palo Alto, California, United States
- Kaiser Permanente-Redwood City
Redwood City, California, United States
- Kaiser Permanente-Richmond
Richmond, California, United States
- Kaiser Permanente-Roseville
Roseville, California, United States
- Sutter Roseville Medical Center
Roseville, California, United States
- Kaiser Permanente Downtown Commons
Sacramento, California, United States
- Kaiser Permanente-South Sacramento
Sacramento, California, United States
- Sutter Medical Center Sacramento
Sacramento, California, United States
- University of California Davis Comprehensive Cancer Center
Sacramento, California, United States
- Salinas Valley Memorial
Salinas, California, United States
- California Pacific Medical Center-Pacific Campus
San Francisco, California, United States
- Kaiser Permanente-San Francisco
San Francisco, California, United States
- Ucsf Medical Center-Mission Bay
San Francisco, California, United States
- Kaiser Permanente-Santa Teresa-San Jose
San Jose, California, United States
- Kaiser Permanente San Leandro
San Leandro, California, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 26 Oct 2018
- Primary completion
- 23 Aug 2023
- Completion
- 1 Sept 2027
- Last update posted
- 26 Oct 2026
- Registered enrollment
- 298
- Registry id
- NCT03375320
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 4 Nov 2026. Registry facts are shown as registered by the study sponsor; FindMyKOL does not interpret them.